CompletedPhase 2NCT03452111
Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception
Studying Multiple endocrine neoplasia type 1
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Premier Research
- Principal Investigator
- Diana Blithe, PhDEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Intervention
- Nestorone + Testosterone Combination Gel(drug)
- Enrollment
- 420 enrolled
- Eligibility
- 18-50 years · All sexes
- Timeline
- 2018 – 2024
Study locations (17)
- UC Davis Health, Sacramento, California, United States
- The Lunquist Institute at Harbor-UCLA Medical Center, Torrance, California, United States
- Comprehensive Women's Health Center, Denver, Colorado, United States
- University of Kansas, Kansas City, Kansas, United States
- Oregon Health & Science University, Portland, Oregon, United States
- University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
- University of Utah, Salt Lake City, Utah, United States
- Eastern Virginia Medical School-EVMS Obstetrics & Gynecology, Norfolk, Virginia, United States
- University of Washington Medical Center & Health Sciences, Seattle, Washington, United States
- Centro de Medicina Reproductiva Shady Grove Chile, Santiago, Vitacura, Chile
- Chilean Institute of Reproductive Medicine, Santiago, Chile
- University of Bologna, Italy, Bologna, Italy
- Kenyatta National Hospital, Nairobi, Kenya
- Karolinska Institutet, Stockholm, Sweden
- University of Edinburgh, Edinburgh, United Kingdom
- +2 more locations on ClinicalTrials.gov
Collaborators
Population Council · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03452111 on ClinicalTrials.govOther trials for Multiple endocrine neoplasia type 1
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06430021Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 MutationCentre Hospitalier Universitaire Dijon
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04530916Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal WomenColorado State University
- RECRUITINGNCT03966612Study and Monitoring of Multiple Endocrine Neoplasia Type 1Centre Hospitalier Universitaire Dijon
- RECRUITINGNCT03348501Study and Follow-up of Multiple Endocrine Neoplasia Type 1Centre Hospitalier Universitaire Dijon
- ACTIVE NOT RECRUITINGNCT03048279Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2M.D. Anderson Cancer Center